Belite Bio BLTE
NASDAQ BLTE
$155.94 -0.58 (-0.37%)
At close: Nov 11, 2026 · 4:00 PM EST

Belite Bio (BLTE) Other Accumulated Expenses (2021 - 2025)

Updated

Belite Bio (BLTE) posted Other Accumulated Expenses of $241,000 for Q4 2025, down 12.7% from $276,000 a year earlier and down 9.1% from the prior quarter.

Analysis

Belite Bio (BLTE) Other Accumulated Expenses (2021 - 2025) Analysis & Trends

Since Q4 2021, Belite Bio has reported Other Accumulated Expenses for 6 quarters.

  • Annual Other Accumulated Expenses shows a four-year compound annual growth rate of 35.7% (FY2021 to FY2025).
  • In prior years, Belite Bio's Other Accumulated Expenses was $276,000 in FY2024 (-10.4%), $308,000 in FY2023 (+55.6%), $198,000 in FY2022 (+178.9%) and $71,000 in FY2021.
  • The Q4 2025 figure stands as the lowest quarterly Other Accumulated Expenses since Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Belite Bio 6.16 Bn 6.16 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 599,000.00
Sep 30, 2025 265,000.00
Dec 31, 2024 289,000.00
Dec 31, 2023 149,000.00
Dec 31, 2022 272,000.00
Dec 31, 2021 147,000.00
API Access

Belite Bio Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=BLTE&period=max&api_key=YOUR_API_KEY